n.c.a. Lutetium-177

As Eczacıbaşı-Monrol, we are proud to announce that our new product n.c.a. Lutetium-177's DMF is registered at the FDA.

Eczacıbaşı- Monrol has signed production and distribution agreement with

TELIX PHARMACEUTICALS

Eczacıbaşı-Monrol will be the radiopharmaceutical production partner and distributor in Turkey, Middle East, and North Africa for Telix. Our primary focus will be on the development of TLX-Cdx (Zr-89 girentuximab) to be used for PET imaging of renal cancer.

n.c.a. Lutetium-177

As Eczacıbaşı-Monrol, we are proud to announce that our new product n.c.a. Lutetium-177's DMF is registered at the FDA.

Eczacıbaşı- Monrol has signed production and distribution agreement with

Eczacıbaşı Monrol Nuclear Products

Eczacıbaşı-Monrol Nuclear Products was founded by Bozlu Holding in 1995 and has continued its activities in partnership with Eczacıbaşı İlaç Sanayi since 2008 while leading the development of nuclear medicine in Turkey since its establishment. Eczacıbaşı-Monrol Nuclear Products is a nuclear medicine company that also maintains its expertise all around the world with high-quality radiopharmaceuticals produced at EU-GMP quality and logistics infrastructure.

RESEARCH & DEVELOPMENT

At Eczacıbaşı Monrol Nükleer Ürünler A.Ş., R&D studies include research and preparation of radiopharmaceuticals available in domestic and foreign markets, their equivalents, or new radiopharmaceuticals, as well improvement of existing products and services manufacturing and quality control methods, reduction of manufacturing costs, reduction of adverse environmental effects and prevention of pollution.

n.c.a. Lutetium-177

Eczacıbaşı- Monrol has signed production and distribution agreement with

n.c.a. Lutetium-177

Eczacıbaşı- Monrol has signed production and distribution agreement with

Eczacıbaşı Monrol Nuclear Products

PRODUCTS